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Abstract
Background: Cell therapy for intrinsic urinary sphincter deficiency (ISD) in women has been moderately effective,
and improvements are needed. To improve treatment efficacy, it is important to better understand determinates of
cell efficacy in the different patient cohorts. We have reported that in nonhuman primates the chronicity of ISD
may affect cell efficacy, but additional factors (age, psychosocial stress, hormone status, body weight) can be
associated with many disease/treatment outcomes in women – and these factors are the focus of this study.
Methods: Adult female cynomolgus monkeys were divided into groups: (1) younger (n = 10, 5–8 years of age)
versus older (n = 10, 13–18 years of age); (2) age-matched/socially subordinate (n = 15) versus socially dominant
(n = 15); and (3) age-matched lower body weight (n = 6) versus higher body weight (n = 6). Autologous skeletal
muscle precursor cells (skMPCs, 5 million) were injected into the urinary sphincter 6 weeks after a surgically
induced ISD procedure. Resting and pudendal nerve-stimulated maximal urethral pressures (MUP) were measured
before, and 3 and 6 months post-skMPC treatment and urinary sphincter muscle/collagen content within the
sphincter complex was measured by quantitative histology 6 months posttreatment.
Results: Efficacy of skMPCs on MUP and sphincter muscle/collagen ratios are affected by age (average 40% reduction
in efficacy, p < 0.05 vs. younger NHPs), social stress (average 30% reduction in efficacy, p < 0.05 vs. socially dominant)
and body weight/fasting glucose concentrations (average 35% reduction in efficacy, p < 0.05 vs. lower body weight).
Conclusion: Multiple factors (age, stress-induced dysmenorrhea, and body weight) affect the efficacy of cell therapy to
restore structure and function in the urinary sphincter complex in NHPs with ISD. Consideration of, and alternatives for,
these patient cohorts should be considered.
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Background
Intrinsic urinary sphincter deficiency (ISD) is a common
cause of stress urinary incontinence (SUI) and remains a
significant quality-of-life issue. It is a chronic condition
resulting from aging and childbirth injury to the urinary
sphincter musculature and innervation, becoming clinically
evident in the peri/postmenopausal years [1, 2]. Although
good results of surgical therapy of SUI have been reported
[3], complications are not infrequent [4] and alternative
treatments may be desirable, particularly when surgical
treatment has failed or if surgery poses too great a risk.
Studies using adult skeletal muscle precursor cells
(skMPCs) to induce tissue regeneration and repair of
the damaged urethral sphincter have shown positive re-
sults both in animals [5, 6] and humans [7]. However, cell
therapy for ISD in women has been only moderately suc-
cessful with consistent 50% beneficial effects in around
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50% of women. In contrast, results of preclinical cell stud-
ies have been more optimistic [6]. This apparent difference
in efficacy could be due to multiple issues with animal and
disease modeling, as preclinical studies are usually per-
formed on adult, healthy animal models. Clinical studies,
even with strict inclusion/exclusion criteria, test treat-
ments in a much more diverse population.
Factors known to affect the efficacy of cell therapy are
chronicity of disease, age, hormonal status, and body
weight. We recently reported reduced efficacy of skMPCs
in nonhuman primates (NHPs) with chronic (versus acute)
intrinsic urinary sphincter deficiency (ISD) [8]. Senescence
of stem cells, associated with aging is reported to dra-
matically reduce the effects of muscle regeneration and
the efficacy of muscle cell therapy [9]. Pelvic health in
women has also been shown to be influenced by estrogen
deficiencies [10, 11], which occur as early as perimeno-
pause (35–50 years of age) and in physically or mentally
stressed women. Body weight and prediabetic conditions
can dramatically increase the risk of diseases such as urin-
ary incontinence, and the effects of cell therapy in this
population are unclear [12].
For the past 8 years, we have examined the effects of
autologous skMPC therapy for ISD in female NHPs.
Results consistently showed improvement in urinary
sphincter structure and function. However, there was
variability in the data. The goal of the present study
was to re-examine the data in the context of cell effi-
cacy in older versus younger; heavier versus lighter, and
dominant versus subordinate NHPs.
Methods
Animal model
Studies in adult female nonhuman primates (Macaca
fascicularis) were approved by the Wake Forest University
Institutional Animal Care and Use Committee protocol
number A16-012 and were performed in compliance with
the Animal Welfare Act and the Guide for the Care and
Use of Laboratory Animals. Euthanasia was performed
according to the standards of the American Veterinary
Medical Association.
Design
Over the past 8 years we have studied the effects of au-
tologous skMPC therapy on acute ISD in over 50 female
cynomolgus monkeys. Aging analysis: the ages of the
animals ranged from 5 to 18 years. A sexually mature
female monkey is approximately 4 years of age and lives
for approximately 25 years [13, 14]. Monkeys have a
28-day menstrual cycle and go through menopause be-
tween 22 and 25 years [13, 14].
We retrospectively analyzed the effects of skMPC therapy
in the ten oldest (13–18 years - equivalent to older cycling
women) and the ten youngest (5–8 years - equivalent to
younger cycling women) monkeys from the total number
of monkeys studied. Body weight analysis: the monkeys var-
ied in body weight from 2.8 kg to 6.7 kg. We compared
skMPC treatment effects in six age-matched (10 years of
age) heavier NHPs (5.0–6.7 kg) versus lighter NHPs (2.8–
3.4 kg body weight). Social status analysis: female monkeys,
when housed in social conditions, naturally sort themselves
into dominant versus subordinate social status [13, 14].
Subordinate female NHPs of this species develop impaired
menstrual cyclicity, relative hypoestrogenism, increased
production of stress cortisol, and psychosocial symptoms of
stress (passive behavior toward the dominate NHPs). For
this study, we selected 15 dominant and 15 subordinate
NHPs from the total of 50 and compared the efficacy of
skMPCs on ISD.
The NHP model of ISD
The ISD procedure was done after baseline urodynamic
measures were obtained. The monkeys were sedated
with ketamine 10–15 mg/kg IM, and 1–5% isoflurane
was used for induction and maintenance of anesthesia.
Monkeys were prepared for aseptic surgery, anesthe-
tized, and a lower midline abdominal incision (4 cm in
length) made to expose the pelvic area of the abdomen.
The distal urinary tract was approached using gentle dis-
section of connective tissue just ventral to the urinary
bladder extending dorsally to the bladder neck and
caudally 2 cm to either side of the rhabdosphincter. The
pudendal nerve branches supplying the sphincter (usually
three in number) were identified and then selectively elec-
trocauterized - while not damaging the sphincter directly -
and then transected [15, 16]. Special care was taken not to
damage surrounding structures. The abdomen was closed
in two layers and postoperative support given.
skMPC isolation and injection
A 1 cm3 sample of quadriceps muscle was aseptically re-
moved from anesthetized NHPs and transported in a
wash solution of Dulbecco’s phosphate-buffered saline
(DPBS, HyClone, South Logan, UT, USA) with 1% anti-
biotic/antimitotic (HyClone). The tissue was washed
10 minutes × 3 in fresh wash solution with periodic gen-
tle agitation with a final rinse in DBPS. The sample was
trimmed of unwanted tissue, weighed, and minced into
fragments approximately 0.5 mm2 or less. Digestion
media consisting of 2:1 dispase II (Sigma-Aldrich, St. Louis,
MO, USA): collagenase type I (Worthington, Lakewood,
NJ, USA) per ml of basal media (custom-designed muscle
progenitor cell media, PeproTech, Rocky Hill, NJ, USA)
was added to the minced tissue at 1 ml per 100 mg of tis-
sue. The sample was incubated at 37 °C, 5% CO2 for 45 mi-
nutes. Upon completion, the digestion was terminated
using 2× volume of growth media (PeproTech basal media
plus FBS and custom growth supplements) to digestion
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media and rigorous pipetting was applied. The suspension
was filtered through a 100-micron filter and centrifuged for
5 minutes at 1500 RPM. The supernatant was aspirated,
fresh growth media was added, and spun for a second time.
Then the sample was plated on a pretreated collagen I 100-
mm culture plate (BD Biocoat, Becton Dickinson, Franklin
Lakes, NJ, USA) and incubated for 24 hours at 37 °C, 5%
CO2. The following day, the aspirate was collected and
replated on a new pretreated collagen-coated plate to re-
duce fibroblast contamination in the cell culture. The
skMPCs were isolated and characterized as described previ-
ously [16]. Eight weeks following collection of the sample, 5
million skMPCs were suspended in 2 milliliters of DMEM
without serum and injected directly into the urinary sphinc-
ter complex [at the level of the sphincter skeletal muscle
layer and at four locations (12, 3, 6, and 9 o’clock positions)]
of anesthetized monkeys as described previously [15, 16].
FACS analysis
Cell cultures from passage 2 skMPCs were analyzed by
fluorescence-activated cell-sorting analysis (FACS ana-
lysis), 200,000 cells of each of the fixed samples from the
monkeys were immunolabeled. All cell samples were
pelleted and blocked with the use of Fc Blocking Reagent
(Miltenyi Biotec Inc., Auburn, CA, USA) for 15 minutes.
Immunolabeling followed immediately with mouse mono-
clonal anti-CD34 (550619, BD Pharmingen, San Diego, CA,
USA) antibody, mouse monoclonal anti-CD44 (550989, BD
Pharmingen) antibody, mouse monoclonal anti-CD45
(558411, BD Pharmingen), skeletal muscle actin (1:100,
Thermo Fisher Scientific, Waltham, MA, USA, PA1-
37019), MyoD (myoblast determination protein) (1:100,
Pharmingen), or CD117 (1:100, BioLegend, San Diego,
CA, USA, 104D2). After incubating for 1 hour at 4 °C
all tubes were washed three times and labeled using
species-specific FITC (FI-1000, Vector Laboratories,
Burlingame, CA, USA). A negative control (no primary
antibody, species-matched serum) was run simultan-
eously with each experimental sample. Cell fluores-
cence was measured immediately after staining with a
Becton Dickinson FACS Calibur flow cytometer (BD
Biosciences, San Diego, CA, USA) and data analyzed
using FlowJo software v. 7.1.3 (Tree Star Inc., Ashland,
OR, USA).
Sphincter function
Monkeys were sedated and anesthetized and urodynamic
measures recorded at baseline (before the nerve injury),
and then prior to injections, at 3 months, and 6 months
post-injection using the Life-Tech Urolab Opus System
V (Life-Tech Inc., Stafford, TX, USA) in combination
with a 6 French Millar microtip transducer catheter
(Millar Instruments Inc., Houston, TX, USA) and a rectal
balloon catheter. The catheter was inserted transurethrally
and the residual urine evacuated. Urethral pressure profi-
lometry was performed by automatic withdrawing of the
sensor catheter at 0.5 mm/s. Rectal pressure was mea-
sured with a balloon catheter attached to a transducer
(Life-Tech Inc.). Using the pressure sensors at its tip (dir-
ection upward), a static urethral pressure profile was re-
corded on the urodynamic machine and the maximal
urethral pressure (MUP) in the region of external sphinc-
ter recorded [15, 16]. This process was repeated three
times and the mean of the urethral pressure measure-
ments calculated for each animal. MUP was then mea-
sured during pudendal nerve stimulation.
Collection and analysis of tissues
The monkeys were euthanized for tissue retrieval using
sodium pentobarbital (80–100 mg/kg/intravenously). The
urethra, approximately 1 cm in length, was removed from
the animal, and immersion fixed in 2% phosphate-buffered
formalin for 48 hours and then transferred to 70% ethanol.
Tissue sections were dehydrated in increasing concen-
trations of ethanol, embedded in paraffin, and cut into
5-μm-thick cross sections. Sections used to quantify
sphincter collagen and muscle content, spaced evenly
along the length of the urethra, were fixed and stained
with Masson’s Trichrome, which stains collagen fibers
blue and muscle fibers red. Image analysis was done
using the Image-Pro AMS 6.0 software (Media Cybernet-
ics, Bethesda, MD, USA).
Statistical analysis
MUP and collagen/muscle data were first analyzed with
a one-way ANOVA to detect differences among groups.
Logarithmic transformation was used if data were not
distributed normally around the mean. If the ANOVA
was significant, post hoc analysis (between groups) was
performed using unpaired Student’s t test with a Holm-
Sidak correction for multiple groups. p < 0.05 was con-
sidered statistically significant. Data are presented as
mean plus/minus standard error of the mean.
Results
Cells
Passage 2 cells were analyzed using fluorescence-activated
cell sorting (FACS). The isolated skMPCs expressed
markers for the muscle precursor marker Myo-D, the
stromal marker CD44 and skeletal muscle actin (Fig. 1).
There was very little expression for the early precursor cell
markers CD177, CD34, or Oct4 (Fig. 1). Interestingly,
there was very little difference in expression patterns be-
tween young and old; heavier versus lighter; or dominant
versus subordinate cell cultures. While not shown, there
was also very little difference in the doubling time among
the different cell cultures.
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Effects of age
Figures 2 and 3 depict the effects of skMPC therapy on
maximal urinary sphincter pressure (MUP), and sphincter
collagen/muscle content in younger (5–8 years of age) ver-
sus older (13–18 years of age) monkeys. MUP values
(Fig. 2) in the combined and younger animals were greater
than the ISD/no treatment groups (p < 0.05). MUP values
in younger animals was greater than that of older animals
(p < 0.05). The effects of age on sphincter collagen/muscle
content (Fig. 3) mirror that of the MUP results. The injury
procedure changed the collagen/muscle ratio from a
muscle-dominant to a collagen-dominant sphincter
(p < 0.05). Treatment with skMPC increased the amount
of muscle in the urinary sphincter in the combined and
Fig. 1 FACS analysis of skMPCs. Fluorescence-activated cell-sorting analysis (FACS analysis) was performed on passage 2 skMPCs from the
monkeys included in this retrospective analysis. This figure represents the findings from one monkey in the ISD/skMPC-treated group of a
younger (5-year-old), normal weight (3.1 kg), dominant monkey. The percentage of FITC-labeled cells (compared to serum controls) is shown
for each of the cell markers
Fig. 2 Maximal urethral pressures (MUP) in the older versus younger
monkeys. This figure depicts the percent changes in maximal
urethral pressure (MUP) from baseline values (before injury) in: the
“Control” group (no ISD/no treatment); ISD/no treatment “No Tx”
group; the “Combined” (ISD/skMPC treatment group); the “Younger”
(age 5–8 years) and the “Older” (age 13–15 years) groups. *p < 0.05
vs. NoTx. §p < 0.05 vs. older. Values are mean ± SEM
Fig. 3 Sphincter muscle/collagen content in the older versus
younger monkeys. This figure depicts the percent of urinary
sphincter complex that is muscle versus collagen as determined
from cross-sectional areas of the sphincter stained with Mason’s
Trichrome. These values are shown for: the “Control” group (no
ISD/no treatment); ISD/no treatment “No Tx” group; the “Combined”
(ISD/skMPC treatment group); the “Younger” (age 5–8 years) and the
“Older” (age 13–15 years) groups. *p < 0.05 vs. Control. §p < 0.05 vs.
Younger. Values are mean ± SEM. The statistical significance markers
reflect changes in both the collagen and muscle content
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the younger groups (p > 0.05 vs. Control), but not the
older group (p < 0.05 vs. Control and younger group).
There were not enough numbers of NHPs to do an
interactive assessment of age and body weight with age
and social status.
Body weight
Monkeys in our studies varied a great deal in their body
weight. We compared the effects of skMPC in monkeys
with a body weight (2.8–3.4 kg) versus those whose body
weight was 5.0–6.7 kg (Figs. 4 and 5). skMPC increased
the MUP values in all three groups (Combined, lower
body weight - LBW, higher body weight - HBW) com-
pared to no treatment (p < 0.05) (Fig. 4). However, the
MUP values of the HBW group remained significantly
lower than the baseline and Control groups (p < 0.05).
Again the sphincter collagen/muscle content mirrored
the effects of skMPCs on MUP values (Fig. 5). Injury
produced a collagen-rich sphincter and treatment re-
versed this relationship to a muscle-rich lesion in the
Combined and LBW groups (p < 0.05), but not the HBW
monkeys (p > 0.05 vs. Injury). There were not enough
numbers of animals to look at interactive effects of body
weight and age or social status.
Social status
In monkeys who are pair-housed, one is the dominant
and one is the subordinate animal. This creates a social
stress condition where the subordinate individual has in-
crease plasma levels of cortisol and impaired menstrual
cyclicity [13, 14]. We compared the effects of skMPC
therapy in these two social groups (Figs. 6 and 7). skMPC
therapy in dominant monkeys had a marked effect on
increasing MUP values from post-injury values (p < 0.05)
and was the only group to restore MUP values to that of
Control animals (>0.05 vs. Control) (Fig. 6). skMPC
therapy improved MUP values in the combined group
(p < 0.05 vs. no treatment), but did not restore MUP
values to Control values. There was little effect of skMPC
therapy on MUP in the subordinate monkeys (p > 0.05 vs.
no treatment and p < 0.05 vs. Control (Fig. 6). Again,
injury created a collagen-rich sphincter complex (Fig. 7).
skMPC therapy restored the muscle content in the
dominant and Combined groups (p < 0.05 vs. Injury
only and p > 0.05 vs. Control. skMPC therapy had little
effect of sphincter collagen and muscle content in the
Fig. 4 Maximal urethral pressures in the heavier versus lighter
monkeys. This figure depicts the percent changes in maximal
urethral pressure (MUP) from baseline values (before injury) in: the
“Control” group (no ISD/no treatment); ISD/no treatment “No Tx”
group; the “Combined” (ISD/skMPC treatment group); the lighter –
“LBW” (2.8–3.4 kg) and the heavier – “HBW” (5.0–6.7 kg) groups.
*p < 0.05 vs. NoTx. §p < 0.05 vs. LBW. Values are mean ± SEM
Fig. 5 Sphincter muscle/collagen content in the older versus younger
monkeys. This figure depicts the percent of urinary sphincter complex
that is muscle versus collagen as determined from cross-sectional
areas of the sphincter stained with Mason’s Trichrome. These
values are shown for: the “Control” group (no ISD/no treatment);
ISD/no treatment “No Tx” group; the “Combined” (ISD/skMPC treatment
group); the lighter – “LBW” and the heavier – “HBW” groups.
*p < 0.05 vs. Control. §p < 0.05 vs. LBW. Values are mean ± SEM.
The statistical significance markers reflect changes in both the collagen
and muscle content
Fig. 6 Maximal urethral pressures in the dominant versus.
subordinate monkeys. This figure depicts the percent changes in
maximal urethral pressure (MUP) from baseline values (before injury)
in: the “Control” group (no ISD/no treatment); ISD/no treatment
“No Tx” group; the “Combined” (ISD/skMPC treatment group); the
“Dominant” and the “Subordinate” groups. *p < 0.05 vs. NoTx.
§p < 0.05 vs. Subordinate. Values are mean ± SEM
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subordinate monkeys (p < 0.05 vs. Combined and dom-
inant) and p > 0.05 vs. injury.
Discussion
This was a subgroup analysis of previously performed
experiments where the efficacy of skMPC therapy was
compared between older versus younger; heavier versus
lighter; and dominant versus subordinate monkeys. The
rationale for these subgroup analyses was that these fac-
tors (age, body weight and social stress have been shown
to influence the risk of diseases and been shown to influ-
ence, directly or indirectly the efficacy of cell therapies
[8–12]. The major finding of this study was that the effi-
cacy of skMPC therapy was reduced in older monkeys,
in heavier monkeys and in monkeys with psychosocial
stress – associated with reduced endogenous estrogen
production.
Aging and regeneration
Aging is probably one of the most significant risk factors
for urinary incontinence in women [2, 17]. There are
several lines of evidence that aging reduces the ability of
cells to regenerate. Some have reported that the cells
from older versus younger individuals have different re-
generative capacity [9, 18, 19]. It has also been reported
that muscle from older mice contain fewer regenerative
cells [19]. Liu et al [18] report that the muscle environ-
ment of older individuals is not conducive to cell regener-
ation because of transcriptional upregulation of immune
activation and downregulation of mitochondrial biogen-
esis. In the present study, there was no apparent difference
in expression of proteins associated with muscle health,
but the age range between the younger and older monkeys
may not have been great enough to produce these changes
and we did not examine transcription differences between
the younger and older cells. Nonetheless, this age differ-
ence in the monkeys was sufficient to have effects on the
efficacy of cell therapy to restore sphincter function and
structure. To our knowledge, the finding that aging affects
the ability of skMPCs to treat intrinsic sphincter deficiency
is new. However, the mechanisms responsible for these
differences have not been established. Preclinical models
used to test treatment efficacy for urinary incontinence
need to consider the age of the animals being used.
Body weight and regeneration
Like aging, obesity is an important risk factor for urinary
incontinence in women [20]. This association is most
likely explained by metabolic changes within the muscle
tissue [21] that reduce the ability of muscle cells to re-
generate. Not much is known about the effects of obes-
ity on the efficacy of cell therapy to regenerate tissues.
In the present study, we compared skMPC efficacy in two
weight groups of monkeys. The first averaged around 3 kg
and the second around 5.5 kg. This may not seem like a
big difference, but the normal weight for this species is be-
tween 2.5 and 3.0 kg and a 5.5 kg monkey is noticeably
heavier with large amounts of abdominal body fat. Blood
tests did not reveal any differences in fasting glucose or in-
sulin concentrations between these two groups and no
glucose tolerance tests were performed. However, there
was a markedly reduced effect of skMPCs to restore urin-
ary sphincter structure and function in the heavier mon-
keys despite no measurable differences in the skMPCs
themselves. Again this study is limited by the lack of a de-
finitive mechanism explaining the differences in efficacy,
but emphasizes the importance of considering body
weight as an important variable in cell efficacy in both pre-
clinical and clinical studies.
Social status/stress/estrogen and regeneration
Urinary incontinence in women is associated with chan-
ging hormonal status during the perimenopausal and
postmenopausal years [2, 19]. However, it is unclear if
this increased risk is due to the changes in hormones
themselves, or advancing age – which is strongly linked
to muscle atrophy and degeneration [18, 19]. Cynomolgus
female monkeys, like women, have a 28-day menstrual
cycle, natural menarche and menopause, and are social
animals [13, 14]. When placed in social groups, they sort
themselves into dominant and subordinate individuals.
The subordinate individuals have irregular and incomplete
menstrual cycles, increased production of stress hor-
mones, and are more prone to developing vascular disease
[13, 14, 22, 23]. When the female cynomolgus monkeys in
this experiment were assessed for their social status, the
subordinate females had a markedly reduced response to
skMPC therapy compared to the dominant females. We
Fig. 7 Sphincter muscle/collagen content in dominant versus
subordinate monkeys. This figure depicts the percent of urinary
sphincter complex that is muscle versus collagen as determined
from cross-sectional areas of the sphincter stained with Mason’s
Trichrome. Results are shown for the “Control” group (no ISD/no
treatment); ISD/no treatment “No Tx” group; the “Combined” (ISD/
skMPC treatment group); the “Dominant” and the “Subordinate”
groups. *p < 0.05 vs. No Tx. Values are mean ± SEM
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did not measure their sex or stress hormone concentra-
tions, but all previous studies have confirmed reduced es-
trogen production and elevated cortisol responses [13, 14].
The important takeaway message is that, like monkeys,
people live in varying stressful conditions and women can
develop relative dysmenorrhea from intense exercise and
stress [13, 14, 22, 23]. While we have not compared intact
versus ovariectomized monkeys (e.g., almost complete es-
trogen deficiency), it is important that the relative estrogen
deficiency can reduce the efficacy of skMPC therapy.
Limitations of this study
Some limitations have been mentioned. This was a retro-
spective study whose original purpose was not to assess
subgroups. It would have strengthened the study if we had
been able to define mechanisms for the physiological and
structural endpoints or to examine these determinates
separately and interactively. For instance, with the smaller
numbers, it was not possible to determine if age and
weight or age and social status interact to produce even
less responsiveness to cell therapy.
Conclusions
Age, stress-induced dysmenorrhea, and body weight may
affect the efficacy of cell therapies. These findings are
important in helping explain some of the differences in
preclinical and clinical studies. More importantly, if valid
in humans, they identify factors that may affect efficacy
and optimization of cell treatment in these subgroups of
patients.
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